Related Experiment Video
Updated: Jun 1, 2026

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
The Toll-like receptor 4 agonist monophosphoryl lipid a augments innate host resistance to systemic bacterial
Christopher D Romero1, Tushar K Varma, Jason B Hobbs
1Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX 77555-0591, USA.
Abstract:
Monophosphoryl lipid A (MPLA) is a Toll-like receptor 4 (TLR4) agonist that is currently used as a vaccine adjuvant in humans. In this study, we evaluated the effect of MPLA treatment on the innate immune response to systemic bacterial infections in mice. Mice treated with MPLA after burn injury showed improved survival and less local and systemic dissemination of bacteria in a model of Pseudomonas aeruginosa burn wound infection. Prophylactic treatment with MPLA significantly enhanced bacterial clearance at the site of infection and reduced systemic dissemination of bacteria despite causing attenuation of proinflammatory cytokine production during acute intra-abdominal infection caused by cecal ligation and puncture. Administration of MPLA at 1 h after CLP also improved bacterial clearance but did not alter cytokine production. MPLA treatment increased the numbers of granulocytes, double-positive myeloid cells, and macrophages at sites of infection and increased the percentage and total numbers of myeloid cells mediating phagocytosis of bacteria. Depletion of Ly6G(+) neutrophils, but not macrophages, eliminated the ability of MPLA treatment to improve bacterial clearance. The immunomodulatory effects of MPLA were absent in TLR4-deficient mice. In conclusion, these studies show that MPLA treatment significantly augments the innate immune response to bacterial infection by enhancing bacterial clearance despite the attenuation of proinflammatory cytokine production. The enhanced bacterial clearance is mediated, in part, by increased numbers of myeloid cells with effective phagocytic functions at sites of infection and is TLR4 dependent.
Insights
Monophosphoryl lipid A (MPLA) enhances innate immune response to bacterial infections by boosting bacterial clearance. This effect is mediated by myeloid cells and depends on Toll-like receptor 4 (TLR4).
Area of Science:
- Immunology
- Microbiology
Background:
- Monophosphoryl lipid A (MPLA) is a Toll-like receptor 4 (TLR4) agonist used as a vaccine adjuvant.
- The impact of MPLA on innate immune responses during systemic bacterial infections requires further investigation.
Purpose of the Study:
- To evaluate the effect of MPLA treatment on the innate immune response to systemic bacterial infections in mice.
- To determine the mechanisms underlying MPLA's immunomodulatory effects.
Main Methods:
- Mice were treated with MPLA following burn injury or cecal ligation and puncture (CLP).
- Bacterial clearance, dissemination, survival rates, and immune cell populations were assessed.
- The role of neutrophils, macrophages, and TLR4 was investigated.
Main Results:
- MPLA treatment improved survival and reduced bacterial dissemination in a Pseudomonas aeruginosa burn wound infection model.
- MPLA enhanced bacterial clearance and reduced systemic spread in a CLP model, despite attenuating proinflammatory cytokine production.
- MPLA increased myeloid cell numbers and phagocytic activity at infection sites.
- Neutrophil depletion abrogated MPLA's protective effects, while macrophage depletion did not.
- MPLA's effects were dependent on TLR4.
Conclusions:
- MPLA treatment augments the innate immune response to bacterial infections by enhancing bacterial clearance.
- This enhanced clearance is mediated by increased myeloid cell function and is TLR4-dependent.
- MPLA offers a potential therapeutic strategy for bacterial infections.
Related Concept Videos
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Formation of Lipopolysaccharides
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Transduction
Cell-mediated Immune Responses
Regulation of Bacterial Virulence

